Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Open in API
Filings indexed 213 across all filing types
Latest filing 2026-06-01 Governance Information
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
기업지배구조보고서공시
Governance Information Classification · 88% confidence The document is the actual Corporate Governance Report (“기업지배구조 보고서”) containing detailed governance policies, compliance tables, board/executive structure, shareholder meeting information, internal controls, and core governance indicators. It is not a simple publication announcement but a full governance disclosure. This matches the Governance Information category (CGR).
2026-06-01 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is clearly a Korean "분기보고서" (Quarterly Report) covering the first quarter of the 67th fiscal year (Jan 1–Mar 31, 2026). It includes detailed sections such as company overview, business activities, full financial statements (including consolidated statements, notes, auditor’s opinion), management’s analysis and other substantive financial data. It is not merely an announcement or an investor presentation but the full interim financial report itself. Therefore, it falls under the category "Interim / Quarterly Report" (IR). Q1 2026
2026-05-15 Korean
기업가치제고계획(자율공시)
Regulatory Filings Classification · 84% confidence The document is a voluntary corporate disclosure outlining a ‘2026 Corporate Value Enhancement Plan’ including strategic goals (sales growth, profitability improvements, shareholder returns, organizational restructuring, cost reductions, and new product focus). It is not an AGM material, earnings release, financial report, audit document, management discussion, capital/financing update, proxy statement, legal report, dividend notice (although dividends are mentioned, the main subject is a strategic enhancement plan), or any other specific category. Therefore, it falls into the fallback “Regulatory Filings” category (RNS).
2026-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” and provides detailed results of an annual general meeting (AGM), including vote counts and percentages for each resolution (financial statements approval, dividend resolutions, director appointments, etc.). This content is clearly the official disclosure of shareholder voting results at a meeting, matching the “Declaration of Voting Results & Voting Rights Announcements” category (Code: DVA). It is not merely an announcement of a report publication, nor is it a full annual report or other financial statement. Therefore, it is classified as DVA.
2026-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed by Il-Sung IS. It provides a summary of the audit opinion, key financial data (assets, liabilities, profit/loss), and the auditor's name. While it contains financial data, it is a regulatory filing announcing the completion and submission of the audit report to the exchange, rather than the full annual report (10-K) or a standalone audit report document (AR). Given the short length and the nature of the filing as a notification of report submission, it fits the criteria for a Report Publication Announcement (RPA). FY 2025
2026-03-18 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Il-Sung IS Co., Ltd. It includes the independent auditor's opinion, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements for the fiscal years 2024 and 2025. It is not an Annual Report (10-K) as it lacks the broader management discussion and analysis (MD&A) or business overview typically found in a full 10-K, and it is not an announcement (RPA) because it contains the full financial data and audit opinion. FY 2025
2026-03-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.